Primerica, INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
NYSE
Primerica, Inc. announced robust second quarter 2026 financial results, showcasing significant year-over-year growth in revenues, net income, and earnings per share, driven by strong performance in its investment business.
NYSE
Primerica, Inc. has amended and restated its $200 million unsecured revolving credit facility, extending the maturity date to June 2, 2031, and adjusting key financial covenants and margins.
NYSE
Primerica, Inc. held its 2026 annual stockholders meeting, where directors were elected, executive compensation was approved, and the independent auditor was ratified.
NYSE
Primerica Inc. announced robust first-quarter 2026 financial results, driven by record sales in its Investment and Savings Products segment and stable performance in Term Life Insurance.
NYSE
Primerica, Inc. has adopted new bylaws requiring a majority of voting power for shareholders to call a special meeting, while also detailing proxy access rules.
NYSE
Primerica, Inc. announced robust fourth-quarter and full-year 2025 financial results, driven by record Investment and Savings Products sales and increased capital returns to shareholders.
NYSE
Primerica, Inc. announced that long-serving directors Beatriz R. Perez and Gary L. Crittenden will not seek re-election at the upcoming May 2026 annual meeting.
NYSE
Primerica, Inc. reported robust third-quarter 2025 financial results, driven by record Investment and Savings Products sales and significant growth in diluted adjusted operating earnings per share.
NYSE
Primerica, Inc. announced robust second-quarter 2025 adjusted operating financial results, driven by growth in Investment and Savings Products and steady Term Life performance, despite a GAAP net income decline due to prior-year non-recurring items.
NYSE
Primerica held its 2025 annual stockholders meeting on May 14, 2025, where directors were elected and executive compensation was approved.
NYSE
Primerica announced a 9% increase in total revenues to $804.8 million for Q1 2025, driven by a 7% increase in the life-licensed sales force and record Investment and Savings Products (ISP) sales.
NYSE
Primerica announced robust Q4 2024 financial results, highlighted by a record life-licensed sales force and significant growth in investment and savings products.
NYSE
Primerica's CEO, Glenn J. Williams, received a special equity award of $2.5 million in restricted stock units in recognition of the company's 2024 achievements.
NYSE
Primerica has amended its previous 8-K filing to include an additional $2 million in restructuring charges related to its senior health business exit plan, recognized in the third quarter of 2024.
NYSE
Primerica's third quarter 2024 results show significant growth in its sales force, life insurance premiums, and investment product sales, leading to a substantial increase in earnings per share.
NYSE
Primerica's life-licensed sales force has exceeded 150,000 independent representatives, marking a significant milestone for the company.
NYSE
Primerica has announced the appointment of Robert H. Peterman, Jr. as the new Chief Operating Officer, succeeding Gregory C. Pitts who will retire in 2025 after 40 years of service.
NYSE
Primerica is set to divest its ownership of e-TeleQuote Insurance by selling a significant stake to a new investor and relinquishing all remaining rights.
NYSE
Primerica's second quarter results show strong growth in sales and client assets, despite a net loss due to the exit of the Senior Health business.
NYSE
Primerica will abandon its senior health business, e-TeleQuote Insurance, due to a lack of profitability and challenging market conditions, resulting in a significant non-cash charge.
NYSE
Primerica's 2024 annual stockholders meeting saw the election of directors, approval of executive compensation, and ratification of KPMG as the independent auditor.
NYSE
Primerica's first quarter 2024 results show strong growth in recruiting, life insurance premiums, and investment product sales, with a slight offset from a loss in the Senior Health business.
NYSE
Primerica's fourth quarter 2023 results show a 9% increase in diluted earnings per share and a record life-licensed sales force of 141,572, driven by strong recruiting and licensing momentum.